The U.S. Food and Drug Administration (FDA) currently requires a warning about the addictive nature of nicotine to be placed on electronic cigarette advertisements and packaging.
View Article and Find Full Text PDFContext: Current use and potential future uptake of e-cigarettes among youth remain public health concerns in the U.S., even as people who smoke combustible cigarettes could benefit from switching completely to e-cigarettes.
View Article and Find Full Text PDFAims: A warning on e-cigarette packaging is one way the U.S. government can inform the public of known harms of e-cigarette use.
View Article and Find Full Text PDFE-cigarette use among youth presents a public health risk. Yet, cigarette smokers who substantially reduce their smoking or switch completely from traditional combustible cigarettes could benefit. As science about e-cigarettes is continually emerging, any potential warnings are likely to contain uncertain language.
View Article and Find Full Text PDFThis study explored the effectiveness of nuanced messages, described in our study as warnings, that seek to convey the potential benefits of switching from cigarettes to e-cigarettes for adults. The messages were designed to convey the potentially complex idea that e-cigarettes are likely less harmful than combustible cigarettes but that e-cigarettes still present a risk. Eight adult focus groups (N = 37) with varying smoking profiles responded to a set of messages that are used by government agencies and non-government organizations to convey the benefits of switching and ongoing risk associated with e-cigarette use.
View Article and Find Full Text PDFWarnings specifically focused on harm to younger users have been understudied in vaping warning research, even while vaping products may appeal specifically to a younger population through implicit advertising strategies. This study examined how youth and young adult-focused e-cigarette health warning messages and implicit advertising strategies influence affective responses, risk perceptions, cognitive elaboration about e-cigarette harms, and willingness to vape in the future. We recruited young adults (who, at the time, were not smoking combustible cigarettes) aged 18-25 to participate in an online survey experiment with a 3 (warning label type: current FDA/youth and young adult risk-focused/none) × 3 (advertising health message strategy: explicit/implicit/none) + 3 (non-vaping products control) design.
View Article and Find Full Text PDFIntroduction: Under the US Family Smoking Prevention and Tobacco Control Act, the US Food and Drug Administration (FDA) has the authority to implement graphic warning labels (GWLs) on cigarette packages. Neither the original labels proposed by the FDA nor the revised labels include a source to indicate sponsorship of the warnings. This study tests the potential impact of adding a sponsor to the content of GWLs.
View Article and Find Full Text PDFTobacco use and the associated consequences are much more prevalent among low-SES populations in the U.S. However, tobacco-based research often does not include these harder-to-reach populations.
View Article and Find Full Text PDFIntroduction: Legal challenges have blocked the implementation of large, pictorial health warning labels (HWLs) in the U.S. In light of future legal questions the U.
View Article and Find Full Text PDFObjectives: This study examined whether patterns of visual attention to graphic warning labels on images of cigarette packs predict key outcomes associated with warning label effectiveness.
Methods: A mobile lab with 5 eye-tracking stations travelled to socioeconomically disadvantaged communities to recruit biologically confirmed adult smokers (Study 1: N = 725) and middle school youth (Study 2: N = 767). We examined patterns of association between eye-tracking measures and negative emotional responses, health risk beliefs, intentions to quit smoking (Study 1), and susceptibility to smoke in the future (Study 2).